Pharmacogenetics of Chronic Pain and Its Treatment
This paper reviews the impact of genetic variability of drug metabolizing enzymes, transporters, receptors, and pathways involved in chronic pain perception on the efficacy and safety of analgesics and other drugs used for chronic pain treatment. Several candidate genes have been identified in the l...
Saved in:
Main Authors: | Svatopluk Světlík, Karolína Hronová, Hana Bakhouche, Olga Matoušková, Ondřej Slanař |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/864319 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences
by: Muriel Javier, et al.
Published: (2023-06-01) -
Pharmacogenetics of Oral Antidiabetic Drugs
by: Matthijs L. Becker, et al.
Published: (2013-01-01) -
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
by: Andrea Rodríguez-Lopez, et al.
Published: (2024-12-01) -
Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents
by: Amilton Dos Santos-Júnior, et al.
Published: (2016-01-01) -
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
by: N. B. Zakharzhevskaya, et al.
Published: (2015-12-01)